Billroth II With Braun Anastomosis After Radical Distal Gastrectomy for Gastric Cancer

Inclusion criteria

To be enrolled, participants must be phase I-III patients with initial treatment of radical distal gastrectomy and satisfying the following inclusion criteria:

• Histologically proven stage I-III gastric cancer, evaluated as radically resectable
• No synchronous or metachronous cancers
• Patients have signed informed consent forms
• Age 18-80 years old
• No malfunction of cardio-pulmonary, liver, and kidney, ECOG score 0-1
• No emergency surgery needed

Exclusion criteria

Patients will be excluded according to the following criteria:

• Pregnant or lactating women
• Distant metastasis to the liver, lung, bone, supraclavicular lymph nodes, pelvic, or ovarian species and peritoneal dissemination
• Ascites or cachexia
• Suffering from other serious diseases, including cardiovascular, respiratory, kidney, or liver disease, poorly controlled hypertension or diabetes
• Participation in other clinical trials 4 weeks before the enrollment of this trial or still participating in other trials
• Mental illness
• Surgical history whose influence has not been eliminated
• History of another gastric or esophageal malignancy, including stromal tumor, sarcoma, lymphoma, and carcinoid
• Active infection with a fever of over 38°C
• Poor compliance
• Not suitable for this trial because of other clinical or laboratory conditions determined by the researchers